Shih‐Wen Wang1, I‐Chan Lin1
Purpose: Strabismus surgery is frequently required in patients with Graves’ disease, but postoperative quality of life has not been well investigated. We aimed to evaluate the improvement in quality of life among patients with Graves’ disease 1 year after receiving strabismus surgery using a questionnaire.
Method: A cohort of Graves’ disease patients undergoing strabismus surgery between June 2016 and December 2018. A quality‐of‐life questionnaire composed of the functional GO‐QOL questionnaire was utilized in this study. The questionnaires were completed by patients before the surgery and 1 year postoperatively. The main outcome measures were the scores of two GO‐QOL subscales: visual functioning and appearance.
Results: The cohort exhibited 17 patients (1 men/16 women). The mean age was 42.6 years old and all patients were operated for the first time for strabismus. Eight patients (47%) reported a history of surgical orbital decompression. The preoperative and postoperative QOL scores for the subscales of visual functioning were 57.2 ± 25.4 and 67.7 ± 16.7 respectively (mean ± SD, P = 0.079). The preoperative and postoperative QOL scores for the subscales of appearance were 45.6 ± 20.1 and 58.8 ± 20.0, respectively (mean ± SD, P = 0.027). The degree of diplopia was assessed objectively by the Worth four dots test, and subjectively by the Gorman scale. The QOL scores for the appearance subscale were correlated with the degree of diplopia.
Conclusion: This study showed that strabismus surgery significantly improved the quality of life among patients with Graves’ ophthalmopathy, especially in the subscales of appearance.
COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A ?TREAT AND EXTEND? PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12- MONTH INTERIM ANALYSIS OF THE RIVAL STUDY